Last reviewed · How we verify
Propofol I
At a glance
| Generic name | Propofol I |
|---|---|
| Also known as | Propofol |
| Sponsor | Aarhus University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- THRIVE in Sedated Gastrointestinal Endoscopy
- Comparing Inhalation and Total Intravenous Anesthesia Methods
- Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies (NA)
- Investigation of the Optimum PEEP Mechanical Power Relationship
- Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast Cancer
- The Role of Oxygen Reserve Index (ORi) in Apneic Ventilation
- COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial (NA)
- The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol I CI brief — competitive landscape report
- Propofol I updates RSS · CI watch RSS
- Aarhus University Hospital portfolio CI